159 related articles for article (PubMed ID: 19714465)
1. Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25).
Cabrera R; Ararat M; Cao M; Xu Y; Wasserfall C; Atkinson MA; Liu C; Nelson DR
Dig Dis Sci; 2010 Feb; 55(2):484-95. PubMed ID: 19714465
[TBL] [Abstract][Full Text] [Related]
2. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
Cabrera R; Ararat M; Eksioglu EA; Cao M; Xu Y; Wasserfall C; Atkinson MA; Liu C; Nelson DR
Scand J Immunol; 2010 Oct; 72(4):293-301. PubMed ID: 20883314
[TBL] [Abstract][Full Text] [Related]
3. T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.
Lindqvist CA; Christiansson LH; Simonsson B; Enblad G; Olsson-Strömberg U; Loskog AS
Immunology; 2010 Nov; 131(3):371-6. PubMed ID: 20518821
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD4+CD25+CD127
Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
[No Abstract] [Full Text] [Related]
5. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
Cabrera R; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Chang LJ; Liu C; Nelson DR
Cancer Immunol Immunother; 2013 Apr; 62(4):737-46. PubMed ID: 23223899
[TBL] [Abstract][Full Text] [Related]
6. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
7. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
[TBL] [Abstract][Full Text] [Related]
8. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
9. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation.
Brusko TM; Wasserfall CH; Hulme MA; Cabrera R; Schatz D; Atkinson MA
PLoS One; 2009 Nov; 4(11):e7980. PubMed ID: 19956753
[TBL] [Abstract][Full Text] [Related]
10. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.
Liu YQ; Poon RT; Hughes J; Li QY; Yu WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):164-70. PubMed ID: 15633209
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
Li Q; Bao JM; Li XL; Zhang T; Shen XH
Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency and FOXP3 expression of human CD8
Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
[TBL] [Abstract][Full Text] [Related]
15. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
[TBL] [Abstract][Full Text] [Related]
16. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.
Cabrera R; Fitian AI; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Liu C; Nelson DR
Oncol Lett; 2012 Oct; 4(4):840-846. PubMed ID: 23205111
[TBL] [Abstract][Full Text] [Related]
18. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
Wu K; Kryczek I; Chen L; Zou W; Welling TH
Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
[TBL] [Abstract][Full Text] [Related]
19. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
Yang XH; Liu BR; Jiang HC
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
[TBL] [Abstract][Full Text] [Related]
20. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
